Calmark Sweden AB has entered an exclusive distributor agreement with the company Enox Pharma AB regarding marketing and sales of Calmark’s products in the countries Egypt, Iraq, Bahrain, Saudi Arabia and the United Arab Emirates
Through this agreement, Calmark expands its launch in the MENA region, where there is an extensive need for safe and effective diagnostics.
Enox Pharma is a Swedish company specialising in the distribution of life science products and related services between Europe and the MENA region. The company sells innovative, sustainable and efficient solutions to optimise healthcare in the Middle East. Enox Pharma has established relationships with influential persons in clinics and hospitals in these countries, which is important for Calmark’s upcoming launch work.
“The MENA market has a large population and enormous potential for both our Neo products and our COVID-19 product. This agreement is an important milestone in our global sales strategy,” said Anna Söderlund, CEO of Calmark.
“Our mission is to offer the healthcare sector in the MENA region the most innovative life-science products and services from the best sources at a reasonable cost,” said Kefah Esmael, CEO and co-founder of Enox Pharma, ”We are very happy for the new agreement with Calmark, there is a great need for both the Neo and Covid tests!”
“Enox Pharma is a company with solid knowledge and expertise in each country’s cultural and commercial conditions. Through the agreement, we take a grip of this large region,” stated Magdalena Tharaldsen, director of international business development at Calmark.
